Sort
50,496 grants matching “lung cancer”
A Role for KSHV in the Pathogenesis of Malignancies
$625,488Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis
$625,471Ming You · Methodist Hospital Research Institute · R01 · FY2025 · CA
Translation of a Lung Cancer Palliative Care Intervention for Clinical Practice
$625,437Betty R Ferrell · Beckman Research Institute/City Of Hope · R01 · FY2014 · NR
Enabling new translational discoveries using a genomic data-driven nosology
$625,423Atul J Butte · Stanford University · R01 · FY2012 · GM
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
$625,412Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy
$625,359Cohava Gelber · Serpin Pharma, Llc · R44 · FY2025 · CA
ETIOLOGICAL PROCESSES IN THE ONSET AND MAINTENANCE OF ADVERSE HEALTH OUTCOMES IN MALTREATED YOUTH
$625,218Christine M Heim · Pennsylvania State University, The · P50 · FY2019 · HD
ETIOLOGICAL PROCESSES IN THE ONSET AND MAINTENANCE OF ADVERSE HEALTH OUTCOMES IN MALTREATED YOUTH
$625,216Christine M Heim · Pennsylvania State University, The · P50 · FY2018 · HD
Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy
$625,194Richard Leo Wahl · Johns Hopkins University · U01 · FY2013 · CA
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
$625,125Eric Collisson · University Of California, San Francisco · R01 · FY2023 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$625,024Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
CANCER-ASSOCIATED MACROPHAGELIKE (CAML) CELLS TO ENHANCE DETECTION OF EARLY-STAGE LUNG CANCER AND RELAPSE AFTER DEFINITIVE TREATMENT
$625,000Creatv Microtech Inc · · FY2018 · Department of the Army
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer
$624,935Steven M. Dubinett · University Of California Los Angeles · U01 · FY2020 · CA
Fox Chase Cancer Center CCOP-Research Base Program
$624,917Paul F. Engstrom · Fox Chase Cancer Center · U10 · FY2008 · CA
Structural and molecular determinants of protein phosphatase 2A function in lung cancer
$624,837Goutham Narla · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers
$624,800Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2022 · CA
Structural and molecular determinants of protein phosphatase 2A function in lung cancer
$624,772Goutham Narla · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
THYMINE DNA GLYCOSYLASE AS A NOVEL TARGET FOR LUNG CANCER
$624,750The Institute For Cancer Research · · FY2017 · Department of the Army
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures
$624,698Fabien Maldonado · Vanderbilt University Medical Center · R01 · FY2024 · CA
Development of antibacterial agents and materials
$624,681Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$624,603William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Modeling BRAF-fusion driven pediatric brain tumors in the mouse
$624,546Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Modeling BRAF-fusion driven pediatric brain tumors in the mouse
$624,546Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Modeling BRAF-fusion driven pediatric brain tumors in the mouse
$624,546Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Financial incentives for homeless smokers: A community-based RCT
$624,545Travis P. Baggett · Massachusetts General Hospital · R01 · FY2021 · CA